logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On November 5th, CHINA FEIHE (06186) spent 22.0752 million Hong Kong dollars to repurchase 5.216 million shares.

date
18:39 05/11/2025
avatar
GMT Eight
China Feihe (06186) announced that the company will invest HK$220.752 million on November 5, 2025...
CHINA FEIHE (06186) announced that on November 5, 2025, the company spent HKD 22.0752 million to repurchase 5.216 million shares at a repurchase price of HKD 4.20-4.25 per share.
Related Articles
HK Stock
CONSUN PHARMA (01681) spent about 2.9823 million Hong Kong dollars on repurchasing 200,000 shares on November 5th.
HK Stock
MILLIONHOPE IND (01897) issued a profit warning, it is expected that the mid-term profit attributable to shareholders will decrease by about 80% to 95% compared to the previous year.
HK Stock
On November 5th, IVD MEDICAL(01931) spent HKD 26.42 million to repurchase 4.396 million shares.
CONSUN PHARMA (01681) spent about 2.9823 million Hong Kong dollars on repurchasing 200,000 shares on November 5th.
HK Stock
MILLIONHOPE IND (01897) issued a profit warning, it is expected that the mid-term profit attributable to shareholders will decrease by about 80% to 95% compared to the previous year.
HK Stock
On November 5th, IVD MEDICAL(01931) spent HKD 26.42 million to repurchase 4.396 million shares.
HK Stock
RECOMMEND
Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
icon
05/11/2025
Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
icon
05/11/2025
Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
icon
05/11/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.